TARGED TARGETED ENZYME DELIVERY Trademark
Trademark Overview
On Friday, August 22, 2025, a trademark application was filed for TARGED TARGETED ENZYME DELIVERY with the United States Patent and Trademark Office. The USPTO has given the TARGED TARGETED ENZYME DELIVERY trademark a serial number of 79437611. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Wednesday, January 14, 2026. This trademark is owned by TargED Biopharmaceuticals B.V.. The TARGED TARGETED ENZYME DELIVERY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Scientific and technological services; research and development services; laboratory and clinical testing; biotechnology research services; pharmaceutical research services; medical and scientific laboratory services; medical research and development services; research and development in the field of thrombosis treatment; pharmaceutical and biotechnology research for antithrombotic drugs; preclinical and clinical testing of drugs for thrombosis; drug discovery services related to thrombosis; development of biopharmaceuticals for cardiovascular diseases; research in the field of platelet aggregation inhibitors; consultancy services in pharmaceutical research and development; scientific studies related to thrombosis and blood clotting disorders; clinical trials for thrombosis drugs and therapies; design and implementation of drug efficacy studies for thrombosis treatment; genetic research and molecular biology services related to thrombosis; technical data analysis and providing non-down...
Pharmaceutical preparations; medical preparations; dietary supplements for medical purposes; medicinal herbs and extracts; drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis; antithrombotic agents; thrombolytic drugs; coagulation inhibitors; anticoagulants; platelet aggregation inhibitors; hemostatic agents; blood thinners for medical use; therapeutic compounds for thrombosis; pharmaceutical preparations for cardiovascular diseases; pharmaceutical preparations for blood clotting disorders; injectable or intravenous solutions for thrombosis treatment; medicinal products for the treatment of deep vein thrombosis (DVT); medicinal products for pulmonary embolism (PE) management; preclinical or clinical trial medicines for thrombosis research; pharmaceuticals for vascular diseases.
General Information
| Serial Number | 79437611 |
| Word Mark | TARGED TARGETED ENZYME DELIVERY |
| Filing Date | Friday, August 22, 2025 |
| Status | 640 - NON-FINAL ACTION COUNTED - NOT MAILED |
| Status Date | Wednesday, January 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Scientific and technological services; research and development services; laboratory and clinical testing; biotechnology research services; pharmaceutical research services; medical and scientific laboratory services; medical research and development services; research and development in the field of thrombosis treatment; pharmaceutical and biotechnology research for antithrombotic drugs; preclinical and clinical testing of drugs for thrombosis; drug discovery services related to thrombosis; development of biopharmaceuticals for cardiovascular diseases; research in the field of platelet aggregation inhibitors; consultancy services in pharmaceutical research and development; scientific studies related to thrombosis and blood clotting disorders; clinical trials for thrombosis drugs and therapies; design and implementation of drug efficacy studies for thrombosis treatment; genetic research and molecular biology services related to thrombosis; technical data analysis and providing non-downloadable computer software for use in modeling in the field of thrombosis treatment; laboratory services for thrombosis diagnosis and testing; research services related to anticoagulation therapy; research in personalized medicine for thrombosis patients; reference material certification services [quality assessment] in the field of thrombosis treatments; research and development services for biotechnological solutions for thrombosis; scientific advisory and consultation services in thrombosis research. |
| Indication of Colors claimed | The colors aqua green, dark green and grey are claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations; medical preparations; dietary supplements for medical purposes; medicinal herbs and extracts; drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis; antithrombotic agents; thrombolytic drugs; coagulation inhibitors; anticoagulants; platelet aggregation inhibitors; hemostatic agents; blood thinners for medical use; therapeutic compounds for thrombosis; pharmaceutical preparations for cardiovascular diseases; pharmaceutical preparations for blood clotting disorders; injectable or intravenous solutions for thrombosis treatment; medicinal products for the treatment of deep vein thrombosis (DVT); medicinal products for pulmonary embolism (PE) management; preclinical or clinical trial medicines for thrombosis research; pharmaceuticals for vascular diseases. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 27, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | TargED Biopharmaceuticals B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | NL |
Trademark Events
| Event Date | Event Description |
| Thursday, November 27, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, November 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 28, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 7, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, January 14, 2026 | NON-FINAL ACTION WRITTEN |
